NEOVACS SIGNS STRATEGIC SOURCING AGREEMENT TO SUPPLY INTERFERON ALPHA FOR PHASE IIB LUPUS TRIAL
May 05, 2014 11:35 ET
|
NEOVACS
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
NEOVACS SIGNS STRATEGIC SOURCING AGREEMENT TO...